Press Releases

Baylor team shortlisted for Cancer Research UK grantsFeb 15, 2018
A multidisciplinary team of scientists has been shortlisted to the final stages of Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
Classification can lead to new ways to diagnose, treat cancerFeb 12, 2018
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumor growth.
Immunotherapy summit brings together patients, expertsJan 11, 2018
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Research reveals path to ependymoma chemotherapyJan 4, 2018
Dr. Stephen Mack and colleagues have developed a framework for discovering targets in ependymomas, and other cancer that lack known genetic drivers, thereby also providing insights into treatment strategies.
G-quadruplex regulates breast cancer-associated geneDec 21, 2017
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Jeffery Rosen honored for breast cancer research Dec 8, 2017
Dr. Jeffrey Rosen was awarded the American Association for Cancer Research (AACR) Distinguished Lecture in Breast Cancer Research at the San Antonio Breast Cancer Symposium.
Dr. Matthew Ellis named to Forbes’ “Physician Honor Roll"Dec 5, 2017
Dr. Matthew Ellis is one of 27 breast oncologists across the country being recognized by Forbes as an exemplary physician in the field of breast cancer oncology.
Dr. Trey Westbrook named new McNair ScholarDec 5, 2017
Dr. Trey Westbrook has been named the newest McNair Scholar. This recognition will support his work focused on discovering the genes and mechanisms that drive breast cancer and developing the next generation of cancer medicines.
Alex’s Lemonade Stand funds Phase 1 neuroblastoma trialDec 4, 2017
Dr. Andras Heczey and Dr. Leonid Metelitsa received a $1.5 million grant from Alex’s Lemonade Stand Foundation to conduct a first-in-human Phase 1 Neuroblastoma clinical trial.
Baylor only Texas site awarded NCI grant to help end smokingNov 28, 2017
The Dan L Duncan Comprehensive Cancer Center is the only site in the state of Texas that will implement a National Cancer Institute-funded tobacco cessation program for cancer patients.
Managing cancer treatment and holiday season expectationsNov 17, 2017
Experts from Baylor College of Medicine provide guidance to help manage cancer during the holidays, as both a patient and a caregiver.
Study examines battlefield chemicals, prostate cancer linkNov 7, 2017
The link between exposure to battlefield chemicals and prostate cancer in veterans is not well understood, but researchers at Baylor College of Medicine are hoping to change that. 
Low-fat diet may lower postmenopausal pancreatic cancer riskNov 6, 2017
Researchers at Baylor College of Medicine have released the findings of the impact a low-fat diet has on pancreatic cancer risk in postmenopausal women. 
Lumpectomy, lift good combination for breast cancer patientsOct 17, 2017
An effort between a surgical oncologist and plastic surgeon can provide an opportunity for women diagnosed with breast cancer to not only have the lump removed, but also get a breast lift at the same time.
Baylor introduces new metastatic breast cancer programOct 9, 2017
Oct. 13 has been declared Metastatic Breast Cancer Day by the Senate of the State of Texas. In honor of this proclamation, Baylor College of Medicine is launching a new program aimed at fighting the disease.
Better understanding of bladder cancer subtypes might lead to improved treatmentsOct 5, 2017
Researchers have completed a comprehensive molecular characterization of 412 muscle-invasive bladder cancers that resulted in the identification of five cancer subtypes with different susceptibilities to specific therapies.
Rally for Research Grant to fund osteosarcoma researchSep 28, 2017
Baylor College of Medicine has received a Rally for Research Grant from the Rally Foundation for Childhood Cancer Research to support Dr. Tsz-Kwong (Chris) Man and his research in targeting methylome in chemo-resistant osteosarcoma. 
Study outlines precancerous treatment of anal lesionsSep 26, 2017
A new study uses a computer model to offer recommendations for monitoring and/or treating precancerous anal lesions based on a patient’s age
NCI renews lymphoma immunotherapy research grantSep 26, 2017
The Center for Cell and Gene Therapy has received an $11.5 million, five-year renewal grant from the National Cancer Institute to continue advancing translational lymphoma research.
Grant funds chemotherapy-free breast cancer therapy researchSep 21, 2017
A new grant to Baylor College of Medicine from the Department of Defense advances effort to develop effective treatments for HER2-positive breast cancers without chemotherapy.